Cibisatamab Antibody
Cibisatamab is a bispecific T-cell engager targeting CEA on tumor cells and CD3 on T-cells, inducing T-cell-mediated cytotoxicity against CEA-positive cancers. It is utilized in preclinical research for solid tumors like colorectal cancer, supporting both in vitro cell-based assays and in vivo xenograft studies to investigate its therapeutic potential.
Product Specifications
Product Name Alternative
CD3
Target
Integrin, Others
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
3.46 mg/mL
Purity
96.50% (May vary between batches)
Molecular Weight
191.1 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15310817 1 Vial
Lentiviral human PPP1R12A shRNA (UAS) - Lentiviral human PPP1R12A shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
